Organon (OGN) announced the successful closing of the sale of its JADA System to Laborie Medical Technologies Corp.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OGN:
- Organon announces U.S. FDA approved sNDA for Nexplanon
- M&A News: India’s Sun Pharma Eyes $10B Bid for U.S.’ Organon
- Organon and Co put volume heavy and directionally bearish
- Organon, Daiichi Sankyo Europe enter commercialization pact for Nilemdo
- Organon Launches Phase 3 Study on Tapinarof Cream for Atopic Dermatitis in Infants